Procyanidins modify insulinemia by affecting insulin production and degradation

Anna Castell-Auví1, Lídia Cedó, Victor Pallarès

  • 1Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Tarragona, Spain.

Insights

Grape seed procyanidin extract (GSPE) impacts pancreatic beta-cell function, altering insulin secretion and synthesis. These findings suggest GSPE may influence glucose metabolism and insulin regulation in healthy individuals.

Area of Science:

  • Endocrinology
  • Nutritional Science
  • Molecular Biology

Background:

  • Previous research indicates procyanidins influence glucose and insulin levels.
  • Understanding procyanidin effects on pancreatic beta-cells is crucial for metabolic health.

Purpose of the Study:

  • To investigate the impact of grape seed procyanidin extract (GSPE) on beta-cell functionality in a non-pathological setting.
  • To elucidate the mechanisms by which procyanidins affect insulin synthesis, secretion, and degradation.

Main Methods:

  • In vivo studies involved administering varying doses of GSPE to healthy rats.
  • In vitro experiments utilized an INS-1E beta-cell line treated with GSPE.
  • Analysis included insulinemia, glucose stimulation response, gene expression (insulin, Glut2, glucokinase, Ucp2), mitochondrial function, and insulin-degrading enzyme (Ide) activity.

Main Results:

  • GSPE altered insulinemia and reduced glucose-stimulated insulin secretion in isolated islets.
  • Procyanidins down-regulated insulin gene expression and synthesis.
  • In vitro, GSPE impaired mitochondrial ATP synthesis, altered membrane potentials, and modified gene expression related to glucose uptake and insulin degradation.

Conclusions:

  • Grape seed procyanidin extract can modify beta-cell functionality, impacting insulin synthesis, secretion, and degradation even in non-pathological conditions.
  • Cellular membrane potentials and insulin-degrading enzyme (Ide) represent potential targets for procyanidin action.

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...